Acute liver failure with concurrent bupropion and carbimazole therapy

Annals of Pharmacotherapy

Volumn 37, Issue 2, 2003, Pages 220-223

  Khoo, Ai Leng ^a   Tham, Lai San ^b   Lee, Kang Hoe ^b   Lim, Gek Kee ^b   Gonzàlez, Lydia ^b   Robert, Sylvie ^b  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b NONE

Author keywords

Bupropion; Carbimazole; Liver failure

Indexed keywords

AMFEBUTAMONE; CARBIMAZOLE; PARACETAMOL; PROPRANOLOL;

ADULT; ARTICLE; CASE REPORT; DRUG INDUCED DISEASE; DYSPEPSIA; EPIGASTRIC PAIN; HEADACHE; HUMAN; HYPERTHYROIDISM; INSOMNIA; JAUNDICE; KIDNEY FUNCTION; LETHARGY; LIVER BIOPSY; LIVER FAILURE; LIVER TOXICITY; MALE; NAUSEA; PRIORITY JOURNAL; SMOKING CESSATION; XEROSTOMIA;

EID: 0037314906     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002800303700212     Document Type: Article

References (24)

1. Halaris AE, Stern WC, Van Wyck FJ, Reno RM. Evaluation of the safety and efficacy of bupropion in depression. J Clin Psychiatry 1983;44(5 pt 2):101-3.
2. Hurt RD, Sachs DPL, Glover ED, Offord MS, Johnston JA, Dale LC, et al. A comparison of sustained release bupropion and placebo for smoking cessation. N Engl J Med 1997;337:1195-202.
3. Journey DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999;340:685-91.
4. Ascher JA, Cole JO, Colin JN. Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry 1995;56:395-401.
5. Hu KQ, Tiyyagura L, Kanel G, Redeker AG. Acute hepatitis induced by bupropion. Dig Dis Sci 2000;45:1872-3.
6. Shuster J. Two cases of drug induced hepatitis: lamotrigine and bupropion are the culprits. Hosp Pharm 2001:36:39-40.
7. Alvaro D, Onetti-Muda A, Moscatelli R, Atili AF. Acute cholestatic hepatitis induced by bupropion prescribed as pharmacological support to stop smoking. A case report. Dig Liver Dis 2001;33:703-6.
8. Oslin DW, Duffy K. The rise of serum aminotransferases in a patient treated with bupropion. J Clin Psychopharmacol 1993;13:364-5.
9. Blom H, Stolk J, Schreuder HB, von Blomberg-van der Flier M. A case of carbimazole-induced intrahepatic cholestasis. An immune-mediated reaction? Arch Intern Med 1985;145:1513-5.
10. Ozenne G, Manchon ND, Doucet J, Hemet J, Schrub JC, Bercoff E. Carbimazole-induced acute cholestatic hepatitis. J Clin Gastroenterol 1989;11:95-7.
11. Epeirier JM, Pageaux GP, Coste V, Perrigault PF, Bane P, Larrey D, et al. Fulminant hepatitis after carbimazole and propranolol administration. Eur J Gastroenterol Hepatol 1996;8:287-8.
12. Binder C, Lang W. Necrotising hepatitis with a fatal outcome with carbimazole therapy. Dtsch Med Wochenschr 1993;118:1515-9.
13. Sadoul JL, Canivet B, Freychet P. Toxic hepatitis induced by antithyroid drugs: four cases including one with cross-reactivity between carbimazole and benzylthiouracil. Eur J Med 1993;2:473-7.
14. Bartalena L, Bogazzi F, Martino E. Adverse effects of thyroid hormone preparations and antithyroid drugs. Drug Saf 1996;15:53-63.
15. Huang MJ, Liaw YF. Clinical associations between thyroid and liver diseases. J Gastroenterol Hepatol 1995;10:344-50.
16. Product information. Zyban (bupropion). Research Triangle Park: Glaxo Wellcome, 1998.
17. Tucker WE. Preclinical toxicology of bupropion: an overview. J Clin Psychiatry 1983;44(5 pt 2):60-2.
18. Fleet JVW, Manberg PJ, Miller LL, Harto-Truax N, Sato T, Fleck RJ, et al. Overview of clinically significant adverse reactions to bupropion. J Clin Psychiatry 1983;44:191-6.
19. Delmar. Product information. Zyban, 2001.
20. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
21. Larrey D. Drug-induced liver diseases. J Hepatol 2000:32(suppl 1):77-88.
22. Frank NAM, Petra S, Michael PM. Molecular basis of drug-induced immunological liver injury. Semin Liver Dis 1995;15:283-300.
23. Lee WM. Review article: drug-induced hepatotoxicity. Aliment Pharmacol Ther 1993;7:477-85.
24. Hesse LM, Venkatakrishnan K, Court MH, Von Moltke LL, Duan SX, Shader RI, et al. CYP 2B6 mediates the in-vitro hydroxylation of bupropion: potential drug interactions with other antidepressants. Drug Metab Dispos 2000;28:1176-83.